open.spotify.com
Mar 17, 2026, 15:43
How Clinicians Navigate the Challenge of Balancing Clotting and Bleeding in CAD – Vasculearn Network
Vasculearn Network shared a post on LinkedIn:
“Antithrombotic therapy in coronary artery disease isn’t one-size-fits-all anymore.
Heather M. Johnson, Ty J. Gluckman and Davide Capodanno come together in the latest episode of Clot, Clot, Who’s There? to chat about how clinicians are navigating the everyday challenge of balancing clotting and bleeding risk.
From the evolving role of aspirin to P2Y12 monotherapy, dual pathway inhibition, and managing CAD with AFib, the conversation highlights a simple shift in thinking:
Less of ‘What should everyone get?’
More of ‘What’s right for the patient in front of me?’
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting